Synopsys (SNPS) is in focus after unveiling autonomous agentic AI workflows for chip design with Microsoft, while deepening collaborations with Nvidia and Intel on AI-powered tools that aim to streamline complex semiconductor development.

Despite AI partnerships with Microsoft, Nvidia and Intel grabbing headlines, Synopsys’ recent share price return has moved the other way, with the stock down 16.45% over 30 days and 22.22% year to date, while the 1 year total shareholder return has fallen 42.09%. This suggests that recent excitement around new tools is arriving against a backdrop of fading momentum after a stronger multiyear run.

If you like the AI infrastructure angle but want to see what else is out there, now could be a good time to scan 56 AI infrastructure stocks

Bulls argue Synopsys is being mispriced after a sharp pullback despite its central role in AI chip design. Bears see a stock coming off a long run with sentiment cooling. Which story do current valuation markers support next?

Most Popular Narrative: 33.2% Undervalued

The most followed valuation narrative currently places Synopsys fair value at $559.58 per share, compared with the latest close of $373.69. This frames the recent price slide very differently from the market action.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This should drive long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.

Want to see what sits behind that confidence in Synopsys fair value? The core of this narrative is a specific mix of revenue growth, margin rebuild and a rich future earnings multiple tied to those projections. Curious which assumptions need to hold for that to stack up?

Result: Fair Value of $559.58 (UNDERVALUED)

However, there are still clear risks to that Synopsys story, including weaker China demand and higher integration costs from the Ansys deal, which could challenge those assumptions.

Another View: Synopsys Looks Expensive On Earnings Ratios

The SWS DCF model suggests Synopsys is trading about 24.5% below an estimated fair value of $495.11, which leans toward an undervalued story. Yet the current P/E of 92.5x is far above a fair ratio of 48.5x, the US Software industry at 29.6x and peers at 34.1x. Is the market overpaying for growth or underestimating future cash flows?

To see how that earnings multiple gap could close over time and what it might mean for risk or opportunity, See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment on Synopsys clearly split, it makes sense to move quickly, test the data yourself and decide where you stand. To see how those tensions between concern and optimism show up in the numbers, start by weighing the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Synopsys?

If Synopsys has sharpened your focus on quality, do not stop here. Fresh ideas from focused stock lists can help you stress test and refine your next move.

• Target reliable cash generation and capital strength by scanning the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for potential value opportunities that align with your return expectations using the 49 high quality undervalued stocks.
• Spot future standouts early by reviewing the screener containing 21 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.